|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Plasma Renin Activity
MessageThis test was developed and its performance characteristics have been determined by Quest Diagnostics Nichols Institute. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Performance characteristics refer to the analytical performance of the test.
Test Code
10537X
CPT Codes
84244
Preferred Specimen
3 mL plasma (0.4 mL minimum)
Minimum Volume
0.5 mL
Instructions
Centrifuge and separate blood at room temperature. Avoid refrigerated temperatures. When submitting catheterization studies, it is recommended that the referring laboratory retain a portion of each sample. Patient should refrain from taking medications, preferably 3 weeks prior to draw. Patient should be ambulatory for 30 minutes prior to draw. Patient should be on a moderate sodium diet during collection.
Transport Container
EDTA (lavender-top)
Transport Temperature
Frozen, stable 6 months
Specimen Stability
Room temperature: 24 hours
Refrigerated: 24 hours
Frozen: 28 days
Refrigerated: 24 hours
Frozen: 28 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received refrigerated
Methodology
Angiotensin I Generation, Radioimmunoassay
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 4 days
Reference Range
Nonhypertensive adults (upright/sitting): | 0.65 - 5.0 ng/mL/h |
Nonhypertensive children supine: | (ng/mL/hr) |
3-12 months | 15.0 or Less |
1-3 years | 10.0 or Less |
4-6 years | 7.5 or Less |
7-9 years | 5.9 or Less |
10-12 years | 5.3 or Less |
13-15 years | 4.4 or Less |
Nonhypertensive children upright/sitting: | (ng/mL/hr) |
3-12 months | 15.0 or less |
1-3 years | 10.0 or less |
4-6 years | 15.0 or less |
7-9 years | 17.0 or less |
10-15 years | 16.0 or less |
Pediatric data from J Pediatrics (1976) 89:256; Pediat Res (1979) 13:817; and Eur J Pediatr (1994) 153:284. |
Clinical Significance
The measurement of plasma renin activity (PRA) is useful in evaluating hypertension. A normal or high PRA rules out primary aldosteronism, whereas a normal or low PRA helps rule out renal hypertension. Additionally, an elevated PRA may indicate renovascular hypertension due to renal artery stenosis.
Performing Laboratory
Quest Diagnostics Nichols Institute
14225 Newbrook Dr
Chantilly, VA 20153